Advanced search
Publication Cover
International Journal of Nanomedicine Volume 7, 2012 - Issue
Submit an article Journal homepage
117
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles

Nirupama Sabnis1 University of North Texas Health Science Center, Fort Worth, TX
,
Maya Nair1 University of North Texas Health Science Center, Fort Worth, TX
,
Mervyn Israel2 University of Tennessee Health Science Center, Memphis, TN
,
Walter J McConathy3 Texas Tech University Health Sciences Center–Permian Basin, Odessa, TX, USA
&
Andras G Lacko1 University of North Texas Health Science Center, Fort Worth, TXCorrespondence[email protected]
Pages 975-983 | Published online: 22 Feb 2012

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Sarika Sabnis, Nirupama A Sabnis, Sangram Raut & Andras G Lacko. (2017) Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery. International Journal of Nanomedicine 12, pages 1453-1464.
Read now
Rebecca Johnson, Nirupama Sabnis, Xiangle Sun, Ruhani Ahluwalia & Andras G Lacko. (2017) SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer. Breast Cancer: Targets and Therapy 9, pages 383-392.
Read now
Linda Foit, Francis J Giles, Leo I Gordon & Colby Shad Thaxton. (2015) Synthetic high-density lipoprotein-like nanoparticles for cancer therapy. Expert Review of Anticancer Therapy 15:1, pages 27-34.
Read now
Baolong Wang, Yuan Yuan, Lei Han, Li Ye, Xunlong Shi & Meiqing Feng. (2014) Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma. Journal of Drug Targeting 22:1, pages 76-85.
Read now
Haitao Luo, Bingbing Jiang, Bingyun Li, Zhaoliang Li, Bing-Hua Jiang & Yi Charlie Chen. (2012) Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. International Journal of Nanomedicine 7, pages 3951-3959.
Read now

Articles from other publishers (14)

Ameerah A. Radhi, Wedad K. Ali & Fitua Al-Saedi. (2023) Tamoxifen Citrate- loaded synthetic high-density lipoproteins: Assessment of cellular toxicity in breast cancer cells. Al Mustansiriyah Journal of Pharmaceutical Sciences 23:1, pages 58-67.
Crossref
Yongzheng Lu, Xiaolin Cui, Li Zhang, Xu Wang, Yanyan Xu, Zhen Qin, Gangqiong Liu, Qiguang Wang, Kang Tian, Khoon S Lim, Chris J Charles, Jinying Zhang & Junnan Tang. (2022) The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy. Aging and disease 13:2, pages 491.
Crossref
Fereydoun Sadeghi, Abbas Afkhami, Tayyebeh Madrakian & Raouf Ghavami. (2021) A new approach for simultaneous calculation of pIC50 and logP through QSAR/QSPR modeling on anthracycline derivatives: a comparable study. Journal of the Iranian Chemical Society 18:10, pages 2785-2800.
Crossref
Fereydoun Sadeghi, Abbas Afkhami, Tayyebe Madrakian & Raouf Ghavami. (2020) Computational study to select the capable anthracycline derivatives through an overview of drug structure-specificity and cancer cell line-specificity. Chemical Papers 75:2, pages 523-538.
Crossref
Stephen E. Henrich, Bong Jin Hong, Jonathan S. Rink, SonBinh T. Nguyen & C. Shad Thaxton. (2019) Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds. Journal of the American Chemical Society 141:25, pages 9753-9757.
Crossref
Ethan Berney, Nirupama Sabnis, Marlyn Panchoo, Sangram Raut, Rob Dickerman & Andras G. Lacko. (2019) The SR-B1 Receptor as a Potential Target for Treating Glioblastoma. Journal of Oncology 2019, pages 1-10.
Crossref
Keila Isaac-Olivé, Blanca E. Ocampo-García, Liliana Aranda-Lara, Clara L. Santos-Cuevas, Nallely P. Jiménez-Mancilla, Myrna A. Luna-Gutiérrez, Luis. A. Medina, Bhavani Nagarajan, Nirupama Sabnis, Sangram Raut, Laszlo Prokai & Andras G. Lacko. (2019) [ 99m Tc-HYNIC- N -dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging . Nanoscale 11:2, pages 541-551.
Crossref
Sangram Raut, Linda Mooberry, Nirupama Sabnis, Ashwini Garud, Akpedje Serena Dossou & Andras Lacko. (2018) Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. Frontiers in Pharmacology 9.
Crossref
Seyedsina Moeinzadeh & Esmaiel Jabbari. 2017. Springer Handbook of Nanotechnology. Springer Handbook of Nanotechnology 335 361 .
Linda K. Mooberry, Nirupama A. Sabnis, Marlyn Panchoo, Bhavani Nagarajan & Andras G. Lacko. (2016) Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Frontiers in Pharmacology 7.
Crossref
Andras G. Lacko, Nirupama A. Sabnis, Bhavani Nagarajan & Walter J. McConathy. (2015) HDL as a drug and nucleic acid delivery vehicle. Frontiers in Pharmacology 6.
Crossref
Kaylin M. McMahon, Linda Foit, Nicholas L. Angeloni, Francis J. Giles, Leo I. Gordon & C. Shad Thaxton. 2015. Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer. Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer 129 150 .
Danielle M. Charron, Juan Chen & Gang Zheng. 2015. Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer. Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer 103 127 .
Riyaz Basha, Nirupama Sabnis, Kenneth Heym, W. Paul Bowman & Andras G. Lacko. (2014) Targeted Nanoparticles for Pediatric Leukemia Therapy. Frontiers in Oncology 4.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.